Author

N. P. Shah

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 1 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Research Focus:cancer & tumor microenvironment· 1 Assay:electrophysiology· 1 Research Focus:synaptic & neural circuits· 1

Frequent Co-Authors

A. Mase· 1 shared D. T. Avansino· 1 shared F. B. Kamdar· 1 shared F. R. Willett· 1 shared I. Rubio· 1 shared J. M. Henderson· 1 shared J. Roose· 1 shared K. Kulhanek· 1 shared

Activity by Year

2023-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Mase

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

A real-time, high-performance brain-computer interface for finger decoding and quadcopter control

M. S. Willsey, N. P. Shah, D. T. Avansino, N. V. Hahn, R. M. Jamiolkowski, F. B. Kamdar, L. R. Hochberg, F. R. Willett, J. M. Henderson

This paper develops a high-performance brain-computer interface for finger control and quadcopter navigation, achieving fast target acquisition and obstacle course performance.

bioRxiv · Feb 6, 2024Bioengineering

A critical role for PLCG1 in RAS activation by BCR-ABL1 and FLT3-ITD

M. Y. Szeto, A. Mase, K. Kulhanek, S. Banerjee, I. Rubio, J. Roose, N. P. Shah

This study identifies PLCG1 as a mediator of RAS activation by BCR-ABL1 and FLT3-ITD, showing that PLCG1 inhibition enhances sensitivity to TKIs in CML and AML.

bioRxiv · Apr 7, 2023 · PreprintCancer Biology